7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Feb 25, 2025.
The trade is 10.8% of the 4,695 shares held after it.
3 other insiders sold within 30 days.
211 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Controller and CAO Bower Steven R. sold about $134.4K of NPO on Mar 2, 2026; 3 other insiders sold within 30 days and 211 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 40.6% of the 3,200 shares held after it.
3 other insiders sold within 30 days.
211 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Humphrey John sold about $349.3K of NPO on Feb 25, 2026; 3 other insiders sold within 30 days and 211 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Aug 20, 2025.
The trade is 6.7% of the 29,909 shares held after it.
3 other insiders sold within 30 days.
211 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, GC, and CAO McLean Robert Savage sold about $555.0K of NPO on Feb 24, 2026; 3 other insiders sold within 30 days and 211 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Mar 7, 2022.
+2.9% median (+1.7% mean) 90-day return after 3 previous buys.
The trade is 16.1% of the 6,389 shares held after it.
3 other insiders sold within 30 days.
211 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Brueck Felix M. sold about $285.1K of NPO on Feb 23, 2026; 3 other insiders sold within 30 days and 211 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Mar 7, 2022.
+2.9% median (+1.7% mean) 90-day return after 3 previous buys.
The trade is 307.7% of the 1,567 shares held after it.
3 other insiders sold within 30 days.
211 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Brueck Felix M. sold about $1.3M of NPO on Feb 23, 2026, the largest insider sale at the company on our record; 3 other insiders sold within 30 days and 211 funds added in the latest 13F quarter.
26 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM NPO
FY Dec 2025
$1.1B
FY Dec 2024
$1.0B
FY Dec 2023
$1.1B
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$338.8M
Mar 2026
$303.0M
Dec 2025
$295.4M
Sep 2025
$286.6M
Jun 2025
$288.1M
Mar 2025
$273.2M
Dec 2024
$258.4M
Sep 2024
$260.9M
At each fiscal year end
Single quarter
Net margin, TTM
+3.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM NPO
FY Dec 2025
+3.5%
FY Dec 2024
+7.0%
FY Dec 2023
+2.1%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+8.0%
Mar 2026
+9.0%
Dec 2025
-10.8%
Sep 2025
+7.5%
Jun 2025
+9.2%
Mar 2025
+9.0%
Dec 2024
+5.4%
Sep 2024
+7.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Free cash flow, TTM NPO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$35.7M
Mar 2026
$27.4M
Dec 2025
n/a
Sep 2025
$53.4M
Jun 2025
$42.3M
Mar 2025
$13.0M
Dec 2024
n/a
Sep 2024
$48.3M
At each fiscal year end
Single quarter
Debt to equity
0.36x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity NPO
FY Dec 2025
0.42x
FY Dec 2024
0.45x
FY Dec 2023
0.46x
FY Dec 2022
0.57x
FY Dec 2021
0.77x
Jun 2026
0.36x
Mar 2026
0.39x
Dec 2025
0.42x
Sep 2025
0.29x
Jun 2025
0.31x
Mar 2025
0.44x
Dec 2024
0.45x
Sep 2024
0.44x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
needs four quarters of operating cash flow
Cash flow to debt NPO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+2.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity NPO
FY Dec 2025
+2.7%
FY Dec 2024
+5.1%
FY Dec 2023
+1.6%
FY Dec 2022
n/a
FY Dec 2021
+15.1%
Jun 2026
+2.9%
Mar 2026
+2.9%
Dec 2025
+2.7%
Sep 2025
+5.8%
Jun 2025
+5.8%
Mar 2025
+5.9%
Dec 2024
+5.1%
Sep 2024
+3.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets NPO
FY Dec 2025
+1.6%
FY Dec 2024
+2.9%
FY Dec 2023
+0.9%
FY Dec 2022
n/a
FY Dec 2021
+7.0%
Jun 2026
+1.8%
Mar 2026
+1.7%
Dec 2025
+1.6%
Sep 2025
+3.5%
Jun 2025
+3.5%
Mar 2025
+3.4%
Dec 2024
+2.9%
Sep 2024
+2.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+6.7%
operating income after a 22.1% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital NPO
FY Dec 2025
+5.8%
FY Dec 2024
+6.3%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+6.7%
Mar 2026
+6.1%
Dec 2025
+5.8%
Sep 2025
+6.6%
Jun 2025
+6.5%
Mar 2025
+6.3%
Dec 2024
+6.3%
Sep 2024
+4.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+7.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed NPO
FY Dec 2025
+6.8%
FY Dec 2024
+6.2%
FY Dec 2023
+3.2%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+7.5%
Mar 2026
+6.9%
Dec 2025
+6.8%
Sep 2025
+7.0%
Jun 2025
+6.8%
Mar 2025
+6.7%
Dec 2024
+6.2%
Sep 2024
+5.6%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
129.33x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing NPO
FY Dec 2025
112.11x
FY Dec 2024
49.99x
FY Dec 2023
149.28x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
182.09x
Mar 2026
122.27x
Dec 2025
112.11x
Sep 2025
55.67x
Jun 2025
48.01x
Mar 2025
40.35x
Dec 2024
49.99x
Sep 2024
63.35x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$6.2B
market value at close 2026-10-23 on 2026-07-23 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value NPO
FY Dec 2025
$5.1B
FY Dec 2024
$4.0B
FY Dec 2023
$3.6B
FY Dec 2022
$2.7B
FY Dec 2021
$2.9B
Jun 2026
$8.5B
Mar 2026
$5.9B
Dec 2025
$5.1B
Sep 2025
$5.1B
Jun 2025
$4.4B
Mar 2025
$3.8B
Dec 2024
$4.0B
Sep 2024
$3.8B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
FCF yield NPO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -48%, PEG needs growth
PEG, trailing NPO
FY Dec 2025
n/a
FY Dec 2024
0.22x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
0.95x
Jun 2025
0.49x
Mar 2025
n/a
Dec 2024
0.22x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
NPO ranks highest on financial health (71st percentile) and institutional and government (70th), and lowest on growth (45th), among Materials peers.
Profitability
47
Inputs
Return on equity+2.9% · 45 pct, sector of 100
Return on assets+1.8% · 52 pct, sector of 120
Return on invested capital+6.7% · 31 pct, sector of 37
Return on capital employed+7.5% · 58 pct, sector of 96
Financial health
71
Inputs
Debt to equity0.36x · 71 pct, sector of 104
Cash flow to debtneeds four quarters of operating cash flow
Growth
45
Inputs
Revenue growth, YoY+9.0% · 73 pct, sector of 128
Backlog growth, YoY-27.1% · 16 pct, universe of 854
Institutional and government
70
Inputs
Funds adding, latest quarter211 · 70 pct, sector of 118
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
70
Inputs
Short interest, % of float+2.6% · 73 pct, sector of 143
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
New text in Risk Factors, latest 10-K+13.7% · 37 pct, sector of 111
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.